PharmaSGP Holding SE

XETRA PSG.DE

PharmaSGP Holding SE Dividend Per Share for the year ending December 31, 2023: USD 0.54

PharmaSGP Holding SE Dividend Per Share is USD 0.54 for the year ending December 31, 2023, a 12.30% change year over year. Dividend per share represents the dividends distributed per share. Indicates dividend yield potential on a per-share basis.

PharmaSGP Holding SE Dividend Per Share for the year ending December 31, 2022 was USD 0.48, a 0.00% change year over year.
PharmaSGP Holding SE Dividend Per Share for the year ending December 31, 2021 was USD -0.00, a -100.00% change year over year.
PharmaSGP Holding SE Dividend Per Share for the year ending December 31, 2020 was USD 9.65, a 1,776.87% change year over year.
PharmaSGP Holding SE Dividend Per Share for the year ending December 31, 2019 was USD 0.51, a 0.00% change year over year.

Key data

Date	Dividend Per Share	Free Cash Flow Per Share	Return on Assets (ROA)	Return on Equity (ROE)

XETRA: PSG.DE

PharmaSGP Holding SE

CEO	Ms. Natalie Weigand
IPO Date	June 19, 2020
Location	Germany
Headquarters	Lochhamer Schlag 21
Employees	89
Sector	Healthcare
Industries Pharmaceuticals Alcoholic Beverages Cosmetics Drugstores & Retail Pharmacies Eyewear Perfumes & Fragrances Personal Care

Description

PharmaSGP Holding SE manufactures over-the-counter drugs, and other healthcare products in Germany. The company's pharmaceutical products include Baldriparan for the treatment of sleep disorders; Spalt, Formigran, and Kamol massage cream for the treatment of different pain conditions; RubaXX pharmaceutical drops for the treatment of rheumatic pain in bones, tendons, and muscles; Restaxil pharmaceutical drops for the treatment of nerve pain in neck and back; Fulminan, a beauty drink for problems in areas, such as eye area, buttocks, or thighs; DESEO pharmaceutical drops for sexual weakness; Neradin, a drug for sexual dysfunction; and TAUMEA, a drug for the treatment of vertigo. It also offers products for the treatment of chronic indications, including pain and other age-related ailments. The company sells its products through pharmacies and wholesalers. It exports its products to European countries comprising Austria, Italy, Belgium, Spain, and France. The company was founded in 2012 and is based in Gräfelfing, Germany.

Key trends

Past 5 years